Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3KD …,

Published: Jun 11, 2021. Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3Kδ selective inhibitor, in relapsed or …, Published: Jun 11, 2021. Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3Kδ selective inhibitor, in relapsed or …, Read More

Scroll to Top